shRNA hinders the expression of PKM2, the sensitivity of cancer cells to certain agents or drugs, including docetaxel and cisplatin, that induces the cell death of cancer tissues and decreases tumorigenesis [14,15]. This evidence concerns the gene PKM and cancer.